Correlation and comparison of some trace elements and their related proteins in Type 2 Diabetes mellitus in Kalars city/ Kurdistan-Iraq.

  • Hero Saed university of garmian
  • Zeyan Abdullah Ali
Keywords: Type2 diabetes mellitus; trace elements, Ferroxidase, Transferrin, Total Iron biding capacity


The serum levels of trace elements alterations have been linked with Type 2 Diabetes mellitus (T2 DM) and its complication. The Objectives of this study is to detect the correlation relation between serum Chromium, Magnesium (Mg), Zinc (Zn), Copper (Cu), and Iron (Fe) with Fasting Blood Sugar (FBS) in patients with type two diabetes mellitus, also to study the comparison of Ferroxidase, Transferrin, and Total iron binding capacity in patients with type two diabetes mellitus with control groups. A total of forty subjects were included in this study, they were divided in two groups (control and diabetic patients). Fasting blood samples were taken from all participants and analyzed for levels of Cr, Mg, Zn, Cu, and Fe. The concentration of serum trace elements of each sample was determined by using Inductively Coupled Plasma Optical Emission Spectroscopy. A negative correlation was found between Mg, Zn, and Fe level in Type-2 diabetics with FBS, whereas serum copper level shows significant positive correlation with FBS, and chromium shown no significant correlation with FBS. Ferroxidase, and Total binding capacity showed a significant increase, while a significant decrease was found in Transferrin of T2DM.


Download data is not yet available.


1. Sanghani, H., V. Parmar, and A. Khubchandani. 2018. Correlation of trace elements (serum zinc and copper) in type 2 diabetic patients with and without complications. International Journal of Clinical Biochemistry and Research, 5(2): p. 249-253.
2. Praveeena, S., S. Pasula, and K. Sameera. 2013. Trace elements in diabetes mellitus. Journal of clinical and diagnostic research: JCDR, 7(9): p. 1863.
3. Calabrese, E.J. and C. Sacco. 1985. Trace elements and public health. Annual review of public health,6: p. 131-146.
4. Nordberg, M. and G.F. Nordberg. 2016. Trace element research-historical and future aspects. Journal of Trace Elements in Medicine and Biology, 38: p. 46-52.
5. Zhang, H., et al. 2017. Alterations of serum trace elements in patients with type 2 diabetes. Journal of Trace Elements in Medicine and Biology, 40: p. 91-96.
6. Anderson, R.A., et al. 1983. Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables. Metabolism,32(9): p. 894-899.
7. Hans, C.P., D.P. Chaudhary, and D.D. Bansal. 2002. Magnesium deficiency increases oxidative stress in rats.Indian Jornal of Expermental Biology,40:p.1275-1279.
8. Hata, A., et al. 2013. Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama Study. Diabetic Medicine, 30(12): p. 1487-1494.
9. Dibaba, D., et al. 2014. Dietary magnesium intake and risk of metabolic syndrome: a meta‐analysis. Diabetic Medicine, 31(11): p. 1301-1309.
10. Chistiakov, D.A. and N.V. Voronova. 2009. Zn2+‐transporter‐8: A dual role in diabetes. Biofactors, 35(4): p. 356-363.
11. Li, Y.V. 2014. Zinc and insulin in pancreatic beta-cells. Endocrine, 45(2): p. 178-189.
12. El Dib, R., et al.2015. Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance. Cochrane Database of Systematic Reviews, (5):p. 1-43.
13. da Silva Bandeira, V., et al. 2017. Association of reduced zinc status with poor glycemic control in individuals with type 2 diabetes mellitus. Journal of Trace Elements in Medicine and Biology, 44: p. 132-136.
14. Olaniyan, O., et al. 2012. Serum copper and zinc levels in Nigerian type 2 diabetic patients. African Journal of Diabetes Medicine Vol, 20(2).
15. Dai Kim, J., et al. 2020. Serum Transferrin Predicts New-Onset Type 2 Diabetes in Koreans: A 4-Year Retrospective Longitudinal Study. Endocrinology and Metabolism, 35(3): p. 610.
16. Fernández-Real, J.M., D. McClain, and M. Manco.2015. Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes. Diabetes care,38(11): p. 2169-2176.
17. Golizeh, M., et al. 2017. Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes. Free Radical Biology and Medicine, 113: p. 461-469.
18. Worwood, M. 1997. The laboratory assessment of iron status—an update. Clinica chimica acta, 259(1-2): p. 3-23.
19. Fleming, R.E. and P. Ponka. 2012. Iron overload in human disease. New England Journal of Medicine, 366(4): p. 348-359.
20. Kasvosve, I. and J. Delanghe. 2002. Total iron binding capacity and transferrin concentration in the assessment of iron status .Clin Chem Lab Med, 40(10):1014–1018.
21. Harrington, J.M., et al. 2014. Analysis of human serum and whole blood for mineral content by ICP-MS and ICP-OES: development of a mineralomics method. Biological trace element research, 160(1): p. 132-142.
22-International Committee for Standardization in Haematology. 1978. The measurement of total and unsaturated iron‐binding capacity in serum. British Journal of Haematology, 38(2), 281-287.
23. Menden, E.E., et al. 1977. Modification of a p-phenylenediamine oxidase method to permit non-automated ceruloplasmin determinations in batches of rat serum or plasma microsamples. Analytical Letters, 10(3): p. 197-204.
24. Anderson, R.A. 1997. Nutritional factors influencing the glucose/insulin system: chromium. Journal of the American College of Nutrition, 16(5): p. 404-410.
25. Viktorínová, A., et al. 2009. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism, 58(10): p. 1477-1482.
26. Blumberg, D., et al. 1998. Free circulating magnesium and renal magnesium handling during acute metabolic acidosis in humans. American journal of nephrology, 18(3): p. 233-236.
27. Pham, P.-C.T., et al. 2007. Hypomagnesemia in patients with type 2 diabetes. Clinical journal of the American Society of Nephrology, 2(2): p. 366-373.
28. Bandeira, V.d.S. 2017. et al., Association of reduced zinc status with poor glycemic control in individuals with type 2 diabetes mellitus. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 44: p. 132-136.
29. Estakhri, M., et al. 2011. Serum zinc levels in children and adolescents with type-1 diabetes mellitus. Iranian journal of public health, 40(4): p. 83-88.
30. Park, K., et al. 2009. Oxidative Stress and Insulin Resistance. Diabetes Care, 32(7): p. 1302.
31. Sharif, A., et al. 2014. Prevalence and Risk of Anemia in Type-2 Diabetic Patients. Health, Vol.06No.12: p. 5.
32. Sarkar, A., et al. 2010. Copper and ceruloplasmin levels in relation to total thiols and GST in type 2 diabetes mellitus patients. Indian Journal of Clinical Biochemistry, 25(1): p. 74-76.
33. Ebrashy, I.E., et al. 2019. Investigation of association of biomarkers of iron metabolism and insulin resistance in Egyptian patients with impaired glucose metabolism and type 2 diabetes. The Egyptian Journal of Internal Medicine, 31: p. 874.
34. Sabitha, D., et al. 2020. Transferrin Glycation-JCDR-Published Paper. Journal of Clinical and Diagnostic Research, 14: p. BC06-BC09.
How to Cite
Saed, H., & Zeyan Abdullah Ali. (2022). Correlation and comparison of some trace elements and their related proteins in Type 2 Diabetes mellitus in Kalars city/ Kurdistan-Iraq. Al-Qadisiyah Journal of Pure Science, 27(1), chem 17-31.